Utility of Biologics in Inflammatory Diseases
Three review articles examine the possible uses of biologic agents in treating pediatric asthma, controlling the atopic march, and treating monogenic systemic autoinflammatory diseases in
Three review articles examine the possible uses of biologic agents in treating pediatric asthma, controlling the atopic march, and treating monogenic systemic autoinflammatory diseases in
“By investing in children and families who are the most in need, we can shift the developmental trajectory of children who have been most negatively
The American Academy of Pediatrics recently revised its policy statement on the use of postnatal corticosteroids for the management or prevention of chronic lung disease
In two major U.S. pediatric networks, penicillin allergy labels were judged to be “uninformative,” researchers report, “and children were infrequently referred to allergists. Future quality
Nightly use of atropine 0.05% eyedrops significantly lowered the incidence of myopia and the percentage of participants with fast myopic shift at 2 years compared
COVID-19 caused by the omicron variant (B.1.1.529) during pregnancy is associated with increased maternal morbidity and mortality, particularly in women who are symptomatic or unvaccinated,
Infants were protected against delta and, to some degree, omicron COVID-19 infections during the first 6 months of life when their mothers were immunized with
The gap between opioid use disorder and buprenorphine dispensing trends to youth aged 19 years or younger indicated that many individuals are receiving the help
Available for private purchase in Spain since 2015, the 4-component, protein-based meningococcal serogroup B vaccine (4CMenB; Bexsero) was effective in a case–control study for preventing invasive
Prenatal or infant exposure to acid-suppressive medications (ASMs) was not associated with allergic diseases in offspring, researchers report. “However, infant exposure to ASMs was associated